Vitality Watch

Dossier pubmed observational 14-oct-2026
Human cohort, case-control, or epidemiological association

Association of eGFR Discrepancy With Subsequent Frailty in Middle-Aged and Older Adults.

Key claim: A higher eGFR discrepancy (eGFRcys minus eGFRcr) is longitudinally associated with a lower subsequent frailty index and decreased odds of frailty in middle-aged and older adults.

Abstract

BACKGROUND: Creatinine- and cystatin C-based estimated glomerular filtration rate estimates are influenced by different non-GFR determinants. Their difference (eGFRcys-eGFRcr) may therefore provide information beyond either marker alone. We examined its longitudinal association with frailty and exploratory indirect associations through grip strength. METHODS: We analyzed 15,309 observations from 11,174 China Health and Retirement Longitudinal Study participants aged 45 years or older across 2011-2013 and 2015-2018. Standardized eGFR discrepancy was the exposure; follow-up outcomes were the 32-item Frailty Index and frailty (Frailty Index ≥0.25). Linear mixed models and generalized estimating equations accounted for repeated observations. Model 3 was primary; eGFRcys adjustment was a conditional sensitivity analysis. RESULTS: Median age was 60.0 years, and 53.4% of participants were female. A 1-SD higher discrepancy was associated with a lower follow-up Frailty Index (β, -0.503; 95% CI, -0.678 to -0.328; P < 0.001) and lower odds of frailty (OR, 0.851; 95% CI, 0.804-0.900; P < 0.001). Associations persisted after eGFRcys adjustment. Exploratory three-wave analyses showed indirect associations through grip strength, not causal mediation. CONCLUSIONS: Higher eGFR discrepancy was longitudinally associated with lower subsequent frailty burden. Further studies are needed to clarify its clinical interpretation and underlying determinants.

Why this matters

[human-observational] This study links the discrepancy between two clinical kidney-function estimates to subsequent functional vulnerability, extending its relevance beyond kidney assessment to frailty risk. [human-observational] Grip-strength findings suggest the association partly reflects muscle-related differences, but the observational evidence does not establish that changing the discrepancy improves function or reverses aging.

Source

Link

Briefing card

Association of eGFR Discrepancy With Subsequent Frailty in Middle-Aged and Older Adults.
Stage: observational · pubmed · 14-oct-2026

If you have both cystatin C– and creatinine-based eGFR results, a higher cystatin C–minus-creatinine eGFR difference was associated with less subsequent frailty in this cohort, not proven protection from frailty.

A higher eGFR discrepancy (eGFRcys minus eGFRcr) is longitudinally associated with a lower subsequent frailty index and decreased odds of frailty in middle-aged and older adults.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1093/joneph/aajag261

build build 880 · 2bcef25 · 2026-11-18